
SILVERARC CAPITAL MANAGEMENT, LLC
Latest 13F filing data - Q3 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
![]() | EYPT | 231K | $3.29M |
![]() | CDTX | 221K | $21.15M |
![]() | CYTK | 211K | $11.60M |
![]() | INSM | 207K | $29.76M |
![]() | RAPP | 204K | $6.06M |
![]() | DCTH | 203K | $2.19M |
![]() | PHVS | 184K | $4.59M |
![]() | ALKS | 181K | $5.42M |
![]() | CTNM | 166K | $1.95M |
![]() | CNTA | 141K | $3.43M |
![]() | SION | 109K | $3.20M |
![]() | DYN | 100K | $1.26M |
![]() | KNSA | 89K | $3.45M |
![]() | CELC | 89K | $4.38M |
![]() | BIIB | 80K | $11.27M |
![]() | MLYS | 80K | $3.03M |
![]() | ASND | 54K | $10.65M |
![]() | PRAX | 51K | $2.71M |
![]() | IMVT | 50K | $806.00K |
![]() | CRNX | 50K | $2.08M |

EyePoint Pharmaceuticals, Inc.
EYPT
Shares Held
231K
Value
$3.29M

Cidara Therapeutics, Inc.
CDTX
Shares Held
221K
Value
$21.15M

Cytokinetics, Incorporated
CYTK
Shares Held
211K
Value
$11.60M

Insmed Incorporated
INSM
Shares Held
207K
Value
$29.76M

Rapport Therapeutics, Inc. Common Stock
RAPP
Shares Held
204K
Value
$6.06M

Delcath Systems, Inc.
DCTH
Shares Held
203K
Value
$2.19M

Pharvaris N.V.
PHVS
Shares Held
184K
Value
$4.59M

Alkermes plc
ALKS
Shares Held
181K
Value
$5.42M

Contineum Therapeutics, Inc. Class A Common Stock
CTNM
Shares Held
166K
Value
$1.95M

Centessa Pharmaceuticals plc
CNTA
Shares Held
141K
Value
$3.43M

Sionna Therapeutics, Inc.
SION
Shares Held
109K
Value
$3.20M

Dyne Therapeutics, Inc.
DYN
Shares Held
100K
Value
$1.26M

Kiniksa Pharmaceuticals, Ltd.
KNSA
Shares Held
89K
Value
$3.45M

Celcuity Inc.
CELC
Shares Held
89K
Value
$4.38M

Biogen Inc.
BIIB
Shares Held
80K
Value
$11.27M

Mineralys Therapeutics, Inc.
MLYS
Shares Held
80K
Value
$3.03M

Ascendis Pharma A/S
ASND
Shares Held
54K
Value
$10.65M

Praxis Precision Medicines, Inc.
PRAX
Shares Held
51K
Value
$2.71M

Immunovant, Inc.
IMVT
Shares Held
50K
Value
$806.00K

Crinetics Pharmaceuticals, Inc.
CRNX
Shares Held
50K
Value
$2.08M
